Holen Sie sich die Stockscreener-App
4.34
1.28%
0.055
Handel nachbörslich:
4.34
Schlusskurs vom Vortag:
$4.285
Offen:
$4.2
24-Stunden-Volumen:
588.49K
Relative Volume:
0.45
Marktkapitalisierung:
$600.15M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-12.40
EPS:
-0.35
Netto-Cashflow:
$-42.28M
1W Leistung:
+20.22%
1M Leistung:
+21.57%
6M Leistung:
+152.33%
1J Leistung:
+120.87%
1-Tages-Spanne:
$4.12
$4.385
1-Wochen-Bereich:
$3.55
$4.395
52-Wochen-Spanne:
$1.27
$4.395
Compass Therapeutics Inc Stock (CMPX) Company Profile
Firmenname
Compass Therapeutics Inc
Sektor
Branche
Telefon
617-500-8099
Adresse
80 GUEST STREET, BOSTON
Vergleichen Sie CMPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
4.34 | 727.47M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-01 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-02 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Eingeleitet | Guggenheim | Buy |
| 2025-02-19 | Eingeleitet | Piper Sandler | Overweight |
| 2024-12-23 | Eingeleitet | D. Boral Capital | Buy |
| 2024-11-15 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Eingeleitet | Jefferies | Buy |
| 2023-01-27 | Eingeleitet | Stifel | Buy |
| 2022-05-23 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-03-15 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-01-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-12-22 | Eingeleitet | Raymond James | Outperform |
| 2021-12-20 | Eingeleitet | SVB Leerink | Outperform |
| 2021-12-15 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten
Risk adjusted return profile for Compass Therapeutics Inc. analyzedDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Key resistance and support levels for Compass Therapeutics Inc.Layoff News & Daily Volume Surge Trade Alerts - newser.com
Published on: 2025-10-14 00:21:20 - newser.com
Will Compass Therapeutics Inc. stock outperform growth indexesJuly 2025 Price Swings & Consistent Growth Equity Picks - newser.com
Is Compass Therapeutics Inc. stock reversal real or fakeJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Using fundamentals and technicals on Compass Therapeutics Inc.Fed Meeting & Real-Time Volume Analysis Alerts - newser.com
How to monitor Compass Therapeutics Inc. with trend dashboards2025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Why Compass Therapeutics Inc. stock is seen as undervalued2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
Why Compass Therapeutics, Inc. (CMPX) is Skyrocketing So Far in 2025 - MSN
Visual trend scoring systems applied to Compass Therapeutics Inc.July 2025 Outlook & Intraday High Probability Setup Alerts - newser.com
Certain Common Stock of Compass Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 12-OCT-2025. - MarketScreener
Compass Therapeutics (NASDAQ:CMPX) Shares Up 4.8%Here's Why - MarketBeat
Compass Therapeutics (NASDAQ:CMPX) Reaches New 1-Year HighHere's What Happened - MarketBeat
What is Lifesci Capital's Estimate for CMPX Q3 Earnings? - MarketBeat
Key metrics from Compass Therapeutics Inc.’s quarterly dataIndex Update & Precise Buy Zone Tips - newser.com
Compass Therapeutics' (CMPX) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Published on: 2025-10-09 04:14:15 - newser.com
Regression analysis insights on Compass Therapeutics Inc. performanceQuarterly Portfolio Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
How to use a screener to detect Compass Therapeutics Inc. breakoutsWeekly Trade Report & Verified Chart Pattern Signals - newser.com
Will Compass Therapeutics Inc. stock outperform Nasdaq indexForecast Cut & Technical Pattern Recognition Alerts - newser.com
Compass Therapeutics (NASDAQ:CMPX) Coverage Initiated by Analysts at Lifesci Capital - Defense World
Compass Therapeutics (NASDAQ:CMPX) Now Covered by Lifesci Capital - MarketBeat
LifeSci Capital Initiates Coverage of Compass Therapeutics (CMPX) with Outperform Recommendation - Nasdaq
Backtesting results for Compass Therapeutics Inc. trading strategies2025 Market Overview & Safe Entry Momentum Stock Tips - newser.com
Will breakout in Compass Therapeutics Inc. lead to full recoveryPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Compass Therapeutics Inc. stock volume spike explainedEntry Point & Community Trade Idea Sharing Platform - newser.com
Forecasting Compass Therapeutics Inc. price range with options dataTrade Volume Report & Reliable Intraday Trade Alerts - newser.com
Will Compass Therapeutics Inc. stock return to pre crisis levelsRate Cut & Long-Term Capital Growth Strategies - newser.com
What analysts say about Compass Therapeutics Inc stockContrarian Investment Ideas & You’ll Regret Not Buying These Early - earlytimes.in
Compass Therapeutics Inc Stock Analysis and ForecastTrading Volume Trends & Free Tap Rapid Wealth - earlytimes.in
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Compass Therapeutics Inc-Aktie (CMPX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
| ORBIMED ADVISORS LLC | Director |
Apr 09 '25 |
Sale |
1.59 |
3,571,428 |
5,678,571 |
0 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):